• As Manufacturers Catch On to Alternative Funding Programs, More Specialty Patients Routed to Overseas Pharmacies

    figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }McMahon PublishingMore drug manufacturers are identifying and rejecting alternative funding program (AFP) applications, pushing commerically insured
  • Ambulatory Care Pharmacists Drive Higher Specialty Prescription Capture

    figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }pikselstock-stock.adobe.comBy Gina ShawAmbulatory care pharmacists at Yale New Haven Health (YNHH) kept two-thirds of the specialty prescriptions the
  • ASHP Calls on HHS to Halt Lilly’s 340B Data Cutoff

    Editor's note: Updated 6/18 to reflect cut-off date not yet enacted, plus new comments from Jesse Dresser, Esq., of Frier LevittBy Gina ShawIn early June, Eli Lilly gave an initial group of 340B hospitals five business days to turn over detailed claims-level data or lose access to discounted drug pricing, and ASHP is urging federal regulators to step in before the deadline hit.As of mid-June, the threatened cutoff had not taken effect for many of the covered entities that received the notice, ev
  • ASHP Futures 2026: Recognizing Progress in Precepting

    This year at ASHP Futures, Dr. Ted Morton received the ASHP Foundation 2025 Pharmacy Residency Excellence Preceptor Award for his over-three decade career in progressing the evolution of pharmacy precepting practices. In this interview with PPN, Dr. Morton discusses what the recognition means to him and shares some of the important lessons and tips he’s learned on how to effectively improve pharmacy residency precepting and training programs. 
  • Advertisement

  • Revenue Is Critical! Dispel Those Knowledge Gaps!

    Bonnie Kirschenbaum, MS, FASHP,FCSHP“Reimbursement Matters” is a tool for maintaining your health system’s fiscal health. Please email the author at [email protected] with suggestions on reimbursement issues that you would like to see covered.The Drug Price Competition and Patent Term Restoration Act of 1984 (also known as the Hatch-Waxman Amendments) added sections 505(b)(2) and 505(j) to the Federal Food, Drug, and Cosmetic Act (FD&C Act), establishing abbrevia

Follow @newsl_pharmacy on Twitter!